ArticleDiabetes care2020

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

Matthew J Crowley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.